BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1411 related articles for article (PubMed ID: 29353884)

  • 21. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.
    Lin H; Huang ZP; Liu J; Qiu Y; Tao YP; Wang MC; Yao H; Hou KZ; Gu FM; Xu XF
    Sci Rep; 2018 Jul; 8(1):10461. PubMed ID: 29992971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
    He H; Lin C; Lu Y; Wu H
    Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
    He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
    Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
    Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
    Cao Y; Xia F; Wang P; Gao M
    Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
    Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
    Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
    Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Liu C; Liu Z; Li X; Tang X; He J; Lu S
    Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.